| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Syntone Ventures LLC is a 10% Owner at Outlook Therapeutics, Inc.. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $2.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2024 | OTLK Outlook Therapeutics, Inc. | 10% Owner | Buy | 714,286 | $0.00 | - | +72.1% | -2.0% | -83.9% | |
| Feb 3, 2021 | OTLK Outlook Therapeutics, Inc. | 10% Owner | Buy | 3,000,000 | $1.00 | $3,000,000.00 | +17.8% | - | - | |
| Jul 15, 2020 | OTLK Outlook Therapeutics, Inc. | 10% Owner | Buy | 823,045 | $1.22 | $999,999.68 | +5.1% | - | - |